Alzheimer’s disease is one of the most devastating health problems facing America today. Not only does this mind-robbing condition affect more than 5 million Americans today, with the Baby Boomer generation heading to retirement, that number is expected to triple by 2050.
Although there is no cure for Alzheimer’s, just a handful of FDA-approved drugs relieve symptoms, but only for the short-term. What’s more, they come with an array of side effects, including headaches, nausea, weight loss, diarrhea and constipation.
Fortunately, modern medicine has begun to embrace the gut-brain axis — the connection that links your brain to your intestines and emotions. Over time, probiotics have proven their value as a non-drug tool ideally equipped to maintain that important balance, and treat problems like depression.
One day very soon, neurologists may be using probiotics to treat Alzheimer’s, based on a recent clinical trial featured in Frontiers in Aging Neuroscience.
Over the course of the 12-week, double-blind clinical trial, Iranian researchers split 52 Alzheimer’s patients (between ages 60-95) into two groups. One received 200 milliliters of milk enriched with three strains of Lactobacillus (acidophilus, casei and fermentum) and Bifidobacterium bifidum, while a control group was given milk without beneficial bacteria.
(Lactobacillus acidophilus and Lactobacillus casei and Bifidobacterium bifidum are three important ingredients of EndoMune Advanced Probiotic.)
At the beginning and end of the trial, blood samples were taken and all patients were given Mini-Mental State Exams (MMSEs) that measured their cognitive ability on specific tasks like remembering dates, copying pictures, counting backwards and naming objects.
No surprise, patients who received the probiotic mixture improved on their previous MMSE results after 12 weeks, while those in the control group had lower scores.
Patients in the probiotic group also benefitted in other measurable ways, with lower levels of trigylcerides, high-sensitivity C-Reactive Protein (hs-CRP) and Very Low Density Lipoproteins (VLDL) as well as drops in two common measures used to gauge insulin resistance and the production of insulin in the pancreas.
“These findings indicate that change in the metabolic adjustments might be a mechanism by which probiotics affect Alzheimer’s and possibly other neurological disorders,” said senior study author Dr. Mahmoud Salami, according to a press release.
Arguably, the real benefits Alzheimer’s patients received in improved cognitive skills and healthier blood levels may stem from the multiple species of bacteria, not just one.
In fact, it’s possible giving Alzheimer’s patients a multi-species probiotic like EndoMune Advanced Probiotic with 10 proven strains of bacteria every day may have yielded even greater results.